Page last updated: 2024-11-11

temarotene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

temarotene: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436116
CHEMBL ID554474
MeSH IDM0151756

Synonyms (27)

Synonym
temarotene
1,1,4,4-tetramethyl-6-[(e)-2-phenylprop-1-enyl]-2,3-dihydronaphthalene
CHEMBL554474
ro-150788
ro 15-0778
1,1,4,4-tetramethyl-6-[(e)-1-phenylprop-1-en-2-yl]-2,3-dihydronaphthalene
unii-a28g39ij7k
naphthalene, 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2-phenylethenyl)-, (e)-
temaroteno [spanish]
a28g39ij7k ,
1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-((e)-alpha-methylstyryl)naphthalene
temarotene [inn]
naphthalene, 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-((1e)-1-methyl-2-phenylethenyl)-
temaroteno
temarotenum
75078-91-0
temarotenum [latin]
1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl)-2-(phenylethenyl)naphthalene
1,1,4,4-tetramethyl-6-(1-methyl-2-phenylethenyl)-1,2,3,4-tetrahydronaphthalene
naphthalene, 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2-phenylethenyl)-
89410-65-1
1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-((e)-.alpha.-methylstyryl)naphthalene
CS-6663
HY-U00011
(e)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2-phenylethenyl) naphthalene
Q27273528
AKOS040742706

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" At the dosage levels of 1, 2, 3, and 6 mg/kg/day there was no decrease in sebum secretion."( Effect of an orally administered arotinoid, Ro 15-0778, on sebum production in man.
Davey, WP; Denton, SJ; Stranieri, AM; Strauss, JS, 1988
)
0.27
" The concentrations of Ro 15-0778 and isotretinoin were determined in plasma and target tissues of castrated, testosterone-stimulated hamsters after oral and topical dosing and in castrated, testosterone-stimulated rats after oral dosing."( Concentrations of isotretinoin and the arotinoid Ro 15-0778 in plasma and tissues of hamsters and rats.
Chari, SS; Hurley, JF; Shapiro, SS; Vane, FM, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID420836Inhibition of Dictyostelium discoideum AX2 RNase P by double reciprocal plot2009European journal of medicinal chemistry, Jun, Volume: 44, Issue:6
Preparation of spermine conjugates with acidic retinoids with potent ribonuclease P inhibitory activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (52.38)18.7374
1990's9 (42.86)18.2507
2000's1 (4.76)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]